Diferencia entre revisiones de «Acute kidney injury»

Sin resumen de edición
Sin resumen de edición
Línea 6: Línea 6:
#Failure - Serum Cr increased 3.0x baseline OR Cr >4 and acute increase >0.5
#Failure - Serum Cr increased 3.0x baseline OR Cr >4 and acute increase >0.5
#Loss - Complete loss of kidney function for >4wk
#Loss - Complete loss of kidney function for >4wk
#ESRD - Need for renal replacement therapy for >3mo
#[[ESRD]] - Need for renal replacement therapy for >3mo
===Chronic Kidney Disease Stages===
===Chronic Kidney Disease Stages===
*Useful if pt's baseline creatinine is unknown
*Useful if pt's baseline creatinine is unknown
Línea 16: Línea 16:


==Risk Factors==
==Risk Factors==
#Radiocontrast agents
#[[Contrast-Induced Nephropathy|Radiocontrast agents]]
##Esp if GFR <60, hypovolemic  
##Esp if GFR <60, hypovolemic  
#Atherosclerosis
#Atherosclerosis
Línea 23: Línea 23:
#NSAIDs
#NSAIDs
#ACEI/ARB
#ACEI/ARB
#Sepsis
#[[Sepsis]]
#Hypercalcemia
#[[Hypercalcemia]]
#Hepatorenal syndrome
#Hepatorenal syndrome


Línea 33: Línea 33:
##Pharmacologic: diuretics
##Pharmacologic: diuretics
##Third spacing
##Third spacing
###Pancreatitis
###[[Pancreatitis]]
##Skin losses: fever, burns
##Skin losses: fever, burns
##Miscellaneous
##Miscellaneous
Línea 39: Línea 39:
###Salt-losing nephropathy
###Salt-losing nephropathy
###Postobstructive diuresis
###Postobstructive diuresis
#Hypotension
#[[Hypotension]]
##Septic vasodilation
##Septic vasodilation
##Hemorrhage
##Hemorrhage
Línea 50: Línea 50:
###Antihypertensive medications
###Antihypertensive medications
##High-output failure
##High-output failure
###Thyrotoxicosis
###[[Thyrotoxicosis]]
###AV fistula
###AV fistula
#Renal artery and small-vessel disease
#Renal artery and small-vessel disease
Línea 73: Línea 73:
###Caused by more advanced disease due to the prerenal causes
###Caused by more advanced disease due to the prerenal causes
#Nephrotoxins
#Nephrotoxins
##Aminoglycosides, radiocontrast, amphotericin, heme pigments (rhabdo, hemolysis)
##Aminoglycosides, [[Contrast-Induced Nephropathy|radiocontrast]], amphotericin, heme pigments ([[rhabdo, hemolysis)
##Obstruction
##Obstruction
###Uric acid, calcium oxalate, myeloma, amyloid
###Uric acid, calcium oxalate, myeloma, amyloid
Línea 88: Línea 88:
#Small-vessel diseases
#Small-vessel diseases
##Microvascular thrombosis
##Microvascular thrombosis
###Preeclampsia, HUS, DIC, TTP, vasculitis (PAN, SCD, atheroembolism)
###Preeclampsia, [[HUS]], [[DIC]], [[TT]]P, vasculitis (PAN, SCD, atheroembolism)
##Malignant hypertension
##Malignant hypertension
##Scleroderma
##Scleroderma

Revisión del 19:32 9 sep 2014

Background

  • Majority of cases of community-acquired ARF is secondary to volume depletion

RIFLE Classification

  1. Risk - Serum Cr increased 1.5x baseline
  2. Injury - Serum Cr increased 2.0x baseline
  3. Failure - Serum Cr increased 3.0x baseline OR Cr >4 and acute increase >0.5
  4. Loss - Complete loss of kidney function for >4wk
  5. ESRD - Need for renal replacement therapy for >3mo

Chronic Kidney Disease Stages

  • Useful if pt's baseline creatinine is unknown
    • Stage 1: Kidney damage (e.g. proteinuria) and normal GFR; GFR >90
    • Stage 2: Kidney damage (e.g. proteinuria) and mild decr in GFR; GFR 60-89
    • Stage 3: Moderate decrease in GFR; GFR >30-59
    • Stage 4: Severe decrease in GFR; GFR 15-29
    • Stage 5: Kidney failure (dialysis or kidney transplant needed); GFR <15

Risk Factors

  1. Radiocontrast agents
    1. Esp if GFR <60, hypovolemic
  2. Atherosclerosis
  3. Chronic hypertension
  4. Chronic kidney disease
  5. NSAIDs
  6. ACEI/ARB
  7. Sepsis
  8. Hypercalcemia
  9. Hepatorenal syndrome

Etiology

Prerenal

  1. Hypovolemia
    1. GI: decreased intake, vomiting and diarrhea
    2. Pharmacologic: diuretics
    3. Third spacing
      1. Pancreatitis
    4. Skin losses: fever, burns
    5. Miscellaneous
      1. Hypoaldosteronism
      2. Salt-losing nephropathy
      3. Postobstructive diuresis
  2. Hypotension
    1. Septic vasodilation
    2. Hemorrhage
    3. Decreased cardiac output
      1. Ischemia/infarction
      2. Valvulopathy
    4. Pharmacologic
      1. B-blockers
      2. CCBs
      3. Antihypertensive medications
    5. High-output failure
      1. Thyrotoxicosis
      2. AV fistula
  3. Renal artery and small-vessel disease
    1. Embolism: thrombotic, septic, cholesterol
    2. Thrombosis: atherosclerosis, vasculitis, sickle cell disease
    3. Dissection
    4. Pharmacologic
      1. NSAIDs
      2. ACEI/ARB
        1. Observed shortly after initiation of therapy
    5. Microvascular thrombosis
      1. Preeclampsia
      2. HUS
      3. DIC
      4. vasculitis
      5. SCD
    6. Hypercalcemia

Intrinsic

  1. Tubular diseases
    1. Ischemic acute tubular necrosis
      1. Caused by more advanced disease due to the prerenal causes
  2. Nephrotoxins
    1. Aminoglycosides, radiocontrast, amphotericin, heme pigments ([[rhabdo, hemolysis)
    2. Obstruction
      1. Uric acid, calcium oxalate, myeloma, amyloid
      2. Pharmacologic: sulfonamide, triamterene, acyclovir, indinavir
  3. Interstitial diseases
    1. Acute interstitial nephritis: typically a drug reaction (NSAIDs, abx, phenytoin)
    2. Infection: bilateral pyelonephritis, Legionnaire disease, hantavirus
    3. Infiltrative disease: sarcoidosis, lymphoma
    4. Autoimmune diseases: SLE
  4. Glomerular diseases
    1. Rapidly progressive glomerulonephritis
      1. Goodpasture, Wegener granulomatosis, HSP, SLE, membranoproliferative GN
    2. Postinfectious glomerulonephritis
  5. Small-vessel diseases
    1. Microvascular thrombosis
      1. Preeclampsia, HUS, DIC, TTP, vasculitis (PAN, SCD, atheroembolism)
    2. Malignant hypertension
    3. Scleroderma
    4. Renal vein thrombosis

Postrenal

  1. Infants and children
    1. Urethra and bladder outlet
      1. Anatomic malformations
        1. Urethral atresia
        2. Meatal stenosis
        3. Anterior and posterior urethral valves
    2. Ureter
      1. Anatomic malformations
        1. Vesicoureteral reflux (female preponderance)
        2. Ureterovesical junction obstruction
        3. Ureterocele
        4. Retroperitoneal tumor
  2. All ages
    1. Various locations in GU tract
      1. Trauma
      2. Blood clot
    2. Urethra and bladder outlet
      1. Phimosis or urethral stricture (male preponderance)
      2. Neurogenic bladder
        1. DM, spinal cord disease, multiple sclerosis, Parkinson's
        2. Pharmacologic: anticholinergics, a-adrenergic antagonists, opiates
  3. Adults
    1. Urethra and bladder outlet
      1. BPH
      2. Cancer of prostate, bladder, cervix, or colon
      3. Obstructed catheters
    2. Ureter
      1. Calculi, uric acid crystals
      2. Papillary necrosis
        1. SCD, DM, pyelonephritis
      3. Tumor: Ureter, uterus, prostate, bladder, colon, rectum; retroperitoneal lymphoma
      4. Retroperitoneal fibrosis: idiopathic, tuberculosis, sarcoidosis, propranolol
      5. Stricture: TB, radiation, schistosomiasis, NSAIDs
      6. Miscellaneous
        1. Aortic aneurysm
        2. Pregnant uterus
        3. IBD
        4. Trauma

Clinical Features

  • Acute renal failure itself has few symptoms until severe uremia develops:
    • N/V, drowsiness, fatigue, confusion, coma
  • Pts more likely to present w/ symptoms related to underlying cause:
    • Prerenal
      • Thirst, orthostatic light-headedness, decreasing urine output
    • Intrinsic
      • Flank pain, hematuria
        • Nephrolithiasis
        • Papillary necrosis
        • Crystal-induced nephropathy
      • Myalgias, seizures, recreational intoxication
        • Pigment-induced ARF (rhabdo)
      • Darkening urine and edema (esp w/ preceding pharyngitis or cutaneous infection)
        • Acute glomerulonephritis
      • Fever, arthralgia, rash
        • Acute interstitial nephritis
      • Cough, dyspnea, hemoptysis
        • Goodpasture, Wegener granulomatosis
    • Postrenal
      • Alternating oliguria and polyuria is pathognomonic of obstruction
      • Anuria

Diagnosis

  1. Prerenal
    1. BUN/Cr ratio > 20
    2. FeNa <1% ((urine sodium/plasma sodium) / (urine creatinine / serum creatinine))
      1. < 2% for neonates
    3. Urine osm >500
    4. Urine sodium < 20 mEq/L
    5. Specific gravity > 1.020
    6. Fractional excretion of urea < 35%
    7. Microscopic analysis
      1. Hyaline casts
  2. Instrinsic
    1. FeNa >1%
      1. > 2.5% for neonates
    2. Urine Osm <350
    3. Urine sodium > 40 mEq/L
    4. Specific gravity < 1.020
    5. Fractional excretion of urea > 50%
    6. Microscopic analysis
      1. Acute glomerulonephritis: RBCs, casts
      2. Acute tubular necrosis: protein, tubular epithelial cells
  3. Postrenal
    1. FeNa >1%
    2. Urine Osm <350

Work-up

  1. Urine
  2. Prostate exam
  3. UA, urine sodium, urine creatinine, urine urea
  4. ECG (hyperkalemia)

Imaging

  1. CXR
  2. Evidence of volume overload, PNA
  3. US
    1. Test of choice in setting of acute renal failure
    2. Bladder size (post-void)
    3. Hydronephrosis
    4. IVC collapsibility (prerenal)
  4. CT
    1. Useful to determine cause of post renal failure (identification of abdominal masses etc.)
    2. Should generally not be used with IV contrast due to potential risk for CIN
    3. Indicated if hydronephrois found on US in order to define the location of obstruction

Treatment

  1. Treat underlying cause
  2. IVF (prerenal)
  3. Obstruction
    1. Note: Postobstructive diuresis can result in significant volume loss and death
      1. Typically occurs when obstruction has been prolonged / has resulted in renal failure
      2. Admit pts w/ persistent diuresis of >250 mL/h for >2hr
    2. Foley Catheter, consider Coude Catheter
    3. Suprapubic (if Coude fails)
  4. Dialysis
    1. Indicated for:
      1. A: Acidosis (severe)
      2. E: Electrolyte abnormality (e.g. uncontrolled hyperkalemia)
      3. I: Ingestions (lithium, ASA, methanol, ethylene glycol, theophylline)
      4. O: Overload (volume) w/ persistent hypoxia
      5. U: Uremic pericarditis/encephalopathy/bleeding dyscrasia
      6. Also:
        1. Na <115 or >165 mEq/L
        2. BUN >100

Disposition

Admit

See Also

Source

Tintinalli